Vizsgálati helyszín
Beijing Luhe Hospital, Capital Medical University
Beijing, Beijing Municipality 101149, KínaMég nincs intézményhez kötve
- 14futó vizsgálat
- 12lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 26 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis11 vizsgálat
- 2. fázis5 vizsgálat
- 1/2. fázis2 vizsgálat
- 4. fázis1 vizsgálat
- Állapot
- Lezárult10 vizsgálat
- Toboroz6 vizsgálat
- Fut, nem toboroz4 vizsgálat
- Még nem toboroz4 vizsgálat
- Leállították2 vizsgálat
- Fő szponzor
- Janssen Research & Development, LLC3 vizsgálat
- BeiGene2 vizsgálat
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 vizsgálat
- Akeso1 vizsgálat
- Beijing Chao Yang Hospital1 vizsgálat
- és még 17
Futó vizsgálatok
Toboroz
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
NCT07692165· 1/2. fázis· Innatus Therapeutics (Shanghai) Co., Ltd.· Forrás
Contact: Wang
Toboroz
Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)
NCT07587099· Gan Lijun· Forrás
Contact: Guangyao Zhai
Toboroz
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07225946· 3. fázis· Janssen Research & Development, LLC· Forrás
Még nem toboroz
Prognostic Model for MASLD Related Cirrhosis
NCT07082751· Beijing Friendship Hospital· Forrás
Contact: Baohong Xu
Toboroz
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
NCT07010263· 3. fázis· Akeso· Forrás
Contact: Dong Yan, M.D.
Toboroz
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
NCT06993844· 1/2. fázis· Ensem Therapeutics· Forrás
Contact: Dong Yan
Toboroz
Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI)
NCT06429774· Beijing Tiantan Hospital· Forrás
Contact: Weiming Liu, M.D.
Toboroz
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT05686642· 2. fázis· Shanghai Pharmaceuticals Holding Co., Ltd· Forrás
Contact: Yanling Wang
Fut, nem toboroz
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)
NCT05714202· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
NCT05152147· 3. fázis· Jazz Pharmaceuticals· Forrás
Még nem toboroz
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
NCT04995159· Lepu Medical Technology (Beijing) Co., Ltd.· Forrás
Contact: Jincheng Guo
Fut, nem toboroz
A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)
NCT05058040· 4. fázis· Green Valley (Shanghai) Pharmaceuticals Co., Ltd.· Forrás
Fut, nem toboroz
A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
NCT04344158· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Toboroz
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
NCT06950697· Beijing Chao Yang Hospital· Forrás
Contact: Yuan Yuan
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
Feasibility and Preliminary Efficacy of a Theory-driven BALANCE Dietary Program Among Patients With Type 2 Diabetes
NCT07472855· Capital Medical University· Forrás
Lezárult
Prospective, Multicenter, Self-controlled Clinical Trial to Validate Optical Ultrasonic Flow Ratio (OUFR)
NCT06726252· Harbin Medical University· Forrás
Lezárult
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
NCT06353347· 3. fázis· Shenzhen HighTide Biopharmaceutical Ltd.· Forrás
Lezárult
A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis
NCT05975268· 3. fázis· Shanghai Junshi Bioscience Co., Ltd.· Forrás
Lezárult
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480· 2. fázis· Shionogi· Forrás
Leállították
Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
NCT05461794· 2. fázis· BeiGene· Forrás
Leállították
Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN
NCT04743739· 3. fázis· Peking Union Medical College Hospital· Forrás
Lezárult
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
NCT04509674· 3. fázis· Boehringer Ingelheim· Forrás
Lezárult
A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma
NCT04540211· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
NCT04574284· 2. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás
Lezárult
A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations
NCT04083976· 2. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma
NCT03777657· 3. fázis· BeiGene· Forrás
Hibát jelzek